Aurobindo gets final US FDA nod for hypertension drug
Aurobindo Pharma has received final approval from the US Food and Drugs Administration to manufacture and market Ramipril capsules, which are used for the treatment of hypertension.
June 10, 2011 / 15:41 IST
Moneycontrol Bureau
Aurobindo Pharma has received final approval from the US Food and Drugs Administration to manufacture and market Ramipril capsules, which are used for the treatment of hypertension.Aurobindo
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!